| Literature DB >> 35246256 |
Shigeki Kubota1, Hideki Kadone2, Yukiyo Shimizu3, Masao Koda4, Hiroshi Takahashi4, Kousei Miura4, Fumihiko Eto4, Takeo Furuya5, Yoshiyuki Sankai6, Masashi Yamazaki4.
Abstract
OBJECTIVE: The Hybrid Assistive Limb (HAL) has recently been used to treat movement disorders. Although studies have shown its effectiveness for chronic myelopathy, the immediate effects of HAL gait training on lower limb function have not been clarified. We conducted HAL gait training and examined its immediate effects on a 69-year-old man with re-deterioration of myelopathy in the chronic phase after surgery for compression myelopathy. The HAL intervention was performed every 4 weeks for 10 total sessions. Immediately before and after each session, we analyzed the patient's walking ability using the 10-m walk test. In the 4th HAL session, the gastrocnemius muscle activity was measured bilaterally using a synchronized motion capture-electromyogram system.Entities:
Keywords: Exercise therapy; Gait; Spinal cord diseases; Wearable electronic devices
Mesh:
Year: 2022 PMID: 35246256 PMCID: PMC8896224 DOI: 10.1186/s13104-022-05979-4
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1The patient’s symptom progression and the point in time at which Hybrid Assistive Limb training was performed
Assist setting for the patient's hip and knee joints at each HAL session
| HAL session | Hip | Knee | ||||||
|---|---|---|---|---|---|---|---|---|
| Right | Left | Right | Left | |||||
| Flex | Ext | Flex | Ext | Flex | Ext | Flex | Ext | |
| 1 | 8.4 | 12 | 10 | 10 | 12 | 12 | 7 | 10 |
| 2 | 6 | 10 | 5.4 | 9 | 10 | 10 | 5.4 | 9 |
| 3 | 6 | 10 | 5.4 | 9 | 7 | 10 | 2.7 | 9 |
| 4 | 4 | 10 | 5.4 | 9 | 10 | 10 | 6.3 | 9 |
| 5 | 3 | 10 | 2.7 | 9 | 10 | 10 | 6.3 | 9 |
| 6 | 5 | 10 | 4.5 | 9 | 10 | 10 | 6.3 | 9 |
| 7 | 5 | 10 | 4.5 | 9 | 10 | 10 | 6.3 | 9 |
| 8 | 5 | 10 | 4.5 | 9 | 10 | 10 | 6.3 | 9 |
| 9 | 5 | 10 | 4.5 | 9 | 10 | 10 | 6.3 | 9 |
| 10 | 5 | 10 | 4.5 | 9 | 10 | 10 | 6.3 | 9 |
The assist setting is expressed as the value on a scale of 0–20.
Flex, flexion; Ext, extension
Walking ability at baseline and after the HAL intervention
| At baseline | After the HAL intervention | |
|---|---|---|
| 10-m walk test | ||
| Speed (m/sec) | 1.06 | 1.31 |
| Step length (m) | 0.56 | 0.65 |
| Cadence (steps/min) | 114.6 | 121.9 |
| 2-min walk test | ||
| Total walking distance (m) | 142.5 | 156.6 |
At baseline: data were obtained 24 days before the 1st HAL session
After the HAL intervention: data were obtained 5 days after the 10th HAL session